Literature DB >> 9554518

Tumor thickness predicts cervical metastasis in patients with stage I/II carcinoma of the tongue.

T Asakage1, T Yokose, K Mukai, S Tsugane, Y Tsubono, M Asai, S Ebihara.   

Abstract

BACKGROUND: The incidence of cervical metastases after surgery for Stages I/II carcinoma of the tongue is 30-40%. Postoperative cervical metastases are an adverse prognostic factor for patients with this malignancy. The purpose of this study was to evaluate the clinicopathologic factors associated with late cervical metastases in patients with carcinoma of the tongue.
METHODS: The clinicopathologic features of 44 patients with previously untreated Stage I/II carcinoma of the tongue were reviewed. All patients were treated with partial glossectomy only.
RESULTS: Cervical metastases developed in 21 of 44 patients within 5 years. Factors significantly associated with the development of cervical metastases were invasive growth, differentiation, nuclear polymorphism in the deep portion, tumor border, nest formation, infiltrative growth ratio, depth, and thickness. No statistical correlations between cervical metastases and age, gender, tumor location, clinical stage, Brinkman index, alcohol index, mitosis, connective tissue, lymphocytic infiltration, or perineural invasion were found. Multivariate analysis demonstrated that only tumor thickness > 4 mm had a predictive value for cervical metastasis (risk ratio 9.4; 95% confidence interval, 1.5-57.7).
CONCLUSIONS: The current study data indicate that patients with Stage I/II carcinoma of the tongue > 4 mm in thickness are at increased risk for subsequent cervical metastasis. Thus, conservative supraomohyoid neck dissection is indicated in patients with Stage I/II carcinoma of the tongue > 4 mm in thickness.

Entities:  

Mesh:

Year:  1998        PMID: 9554518     DOI: 10.1002/(sici)1097-0142(19980415)82:8<1443::aid-cncr2>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  35 in total

1.  Relationship between histologic thickness of tongue carcinoma and thickness estimated from preoperative MRI.

Authors:  Lorenzo Preda; Fausto Chiesa; Luca Calabrese; Antuono Latronico; Roberto Bruschini; Maria E Leon; Giuseppe Renne; Massimo Bellomi
Journal:  Eur Radiol       Date:  2006-04-25       Impact factor: 5.315

2.  Tumor thickness as an independent risk factor of early recurrence in oral cavity squamous cell carcinoma.

Authors:  Fábio Roberto Pinto; Leandro Luongo de Matos; Filipe Cavalcanti Palermo; Marco Aurélio Vamondes Kulcsar; Beatriz Godói Cavalheiro; Evandro Sobroza de Mello; Venâncio Avancini Ferreira Alves; Cláudio Roberto Cernea; Lenine Garcia Brandão
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-09-27       Impact factor: 2.503

3.  Predictive factors for late cervical metastasis in stage I and II squamous cell carcinoma of the lip.

Authors:  Norberto K Kavabata; Décio N Caly; Ting H Ching; Antonio J Gonçalves; Luis P Kowalski; Cláudio R Cernea
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-06-04       Impact factor: 2.503

4.  Perinerural, lymphovascular and depths of invasion in extrapolating nodal metastasis in oral cancer.

Authors:  Alkananda Sahoo; Swagatika Panda; Neeta Mohanty; Debkant Jena; Niranjan Mishra; Manas R Baisakh
Journal:  Clin Oral Investig       Date:  2019-05-28       Impact factor: 3.573

5.  Guidelines for the Surgical Management of Oral Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Young-Hoon Joo; Jae-Keun Cho; Bon Seok Koo; Minsu Kwon; Seong Keun Kwon; Soon Young Kwon; Min-Su Kim; Jeong Kyu Kim; Heejin Kim; Innchul Nam; Jong-Lyel Roh; Young Min Park; Il-Seok Park; Jung Je Park; Sung-Chan Shin; Soon-Hyun Ahn; Seongjun Won; Chang Hwan Ryu; Tae Mi Yoon; Giljoon Lee; Doh Young Lee; Myung-Chul Lee; Joon Kyoo Lee; Jin Choon Lee; Jae-Yol Lim; Jae Won Chang; Jeon Yeob Jang; Man Ki Chung; Yuh-Seok Jung; Jae-Gu Cho; Yoon Seok Choi; Jeong-Seok Choi; Guk Haeng Lee; Phil-Sang Chung
Journal:  Clin Exp Otorhinolaryngol       Date:  2019-02-02       Impact factor: 3.372

6.  Predictors of locoregional recurrence in T1-2N0 tongue cancer patients.

Authors:  Souichi Yanamoto; Shin-ichi Yamada; Hidenori Takahashi; Goro Kawasaki; Hisazumi Ikeda; Takeshi Shiraishi; Shuichi Fujita; Tohru Ikeda; Izumi Asahina; Masahiro Umeda
Journal:  Pathol Oncol Res       Date:  2013-05-17       Impact factor: 3.201

7.  Affect on survival per increase in each millimeter of tumor depth in tongue cancer.

Authors:  Sandhya Gokavarapu; Murtaza Ahmed; Nagendra Parvataneni; K V V N Raju; Ravi Chander; L M Chandrasekhara Rao S
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-11-04

8.  MRI-derived tumor thickness: an important predictor of outcome for T4a-staged tongue carcinoma.

Authors:  Wei-Lin Chen; Chin-Chuan Su; Chih-Ming Chen; Ming-Che Lee; Hui-Chuan Chen; Mu-Kuan Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-12       Impact factor: 2.503

Review 9.  Metastatic disease in head & neck oncology.

Authors:  Paolo Pisani; Mario Airoldi; Anastasia Allais; Paolo Aluffi Valletti; Mariapina Battista; Marco Benazzo; Roberto Briatore; Salvatore Cacciola; Salvatore Cocuzza; Andrea Colombo; Bice Conti; Alberto Costanzo; Laura Della Vecchia; Nerina Denaro; Cesare Fantozzi; Danilo Galizia; Massimiliano Garzaro; Ida Genta; Gabriela Alejandra Iasi; Marco Krengli; Vincenzo Landolfo; Giovanni Vittorio Lanza; Mauro Magnano; Maurizio Mancuso; Roberto Maroldi; Laura Masini; Marco Carlo Merlano; Marco Piemonte; Silvia Pisani; Adriele Prina-Mello; Luca Prioglio; Maria Gabriella Rugiu; Felice Scasso; Agostino Serra; Guido Valente; Micol Zannetti; Angelo Zigliani
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-04       Impact factor: 2.124

Review 10.  Contemporary management of cancer of the oral cavity.

Authors:  Eric M Genden; Alfio Ferlito; Carl E Silver; Robert P Takes; Carlos Suárez; Randall P Owen; Missak Haigentz; Sandro J Stoeckli; Ashok R Shaha; Alexander D Rapidis; Juan Pablo Rodrigo; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-02-13       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.